Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four-Year Results of the Postconcept Study
Open Access
- 28 July 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (8), 1665-1675
- https://doi.org/10.1111/j.1600-6143.2011.03637.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Similar Lipid Profile But Improved Long-Term Outcomes With Sirolimus After Cyclosporine Withdrawal Compared to Sirolimus With Continuous CyclosporineTransplantation Proceedings, 2009
- Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept StudyAmerican Journal of Transplantation, 2009
- Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of SteroidsAmerican Journal of Transplantation, 2007
- Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationTransplant International, 2004
- De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two YearsAmerican Journal of Transplantation, 2004
- Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol HistologyTransplantation, 2004
- Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent EraAmerican Journal of Transplantation, 2004
- Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2Transplantation, 2002
- SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10Transplantation, 2001
- SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12Transplantation, 2000